Home

Silence Therapeutics Plc (SLN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Silence Therapeutics Plc (SLN)

Go deeper and ask any question about SLN

Company Performance

Current Price

as of Sep 13, 2024

$18.69

P/E Ratio

N/A

Market Cap

$872.07M

Description

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Metrics

Overview

  • HQLondon, GL
  • SectorCommercial Services
  • IndustryMiscellaneous Commercial Services
  • TickerSLN
  • Price$18.69+0.59%

Trading Information

  • Market Cap$872.07M
  • Float85.04%
  • Average Daily Volume (1m)169,086
  • Average Daily Volume (3m)230,060
  • EPS-$1.21

Company

  • Revenue$22.63M
  • Rev Growth (1yr)-93.38%
  • Net Income-$19.64M
  • Gross Margin-341.14%
  • EBITDA Margin-3,044.15%
  • EBITDA-$22.97M
  • EV$699.12M
  • EV/Revenue30.89
  • P/EN/A
  • P/S38.60
Documents